Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension.
van den Meiracker AH, Admiraal PJ, Janssen JA, Kroodsma JM, de Ronde WA, Boomsma F, Sissmann J, Blankestijn PJ, Mulder PG, Man In 't Veld AJ, et al.
van den Meiracker AH, et al. Among authors: mulder pg.
Hypertension. 1995 Jan;25(1):22-9. doi: 10.1161/01.hyp.25.1.22.
Hypertension. 1995.
PMID: 7843749
Free article.
Clinical Trial.